Funded PhD in Ubiquitin-Independent Targeted Protein Degradation for Oncology
- Deadline
- 8 Dec 2026 · 16 days left
- Location
- Cambridge, United Kingdom
- Type
- PhD Position
- Duration
- 48 months · 4 years
- Working language
- English
- Posted
- 20 Nov 2026
- Verified
- 20 Nov 2026
About this opportunity
The Department of Pharmacology at the University of Cambridge is offering a four-year PhD studentship, run with AstraZeneca, on next-generation targeted protein degradation (TPD) for cancer. The project aims to build a TPD platform that works without ubiquitin by co-opting the protein Midnolin. Funding covers a stipend and Home-rate tuition fees.
What is offered
- A fully funded 4-year PhD studentship (stipend plus tuition fees at the Home rate).
- Research on ubiquitin-independent protein degradation: studying how Midnolin is regulated in the cell and engineering Midnolin-based degraders aimed at oncology targets.
- Joint supervision between academia and industry: Dr Catherine Lindon (host lab) and Professor Laura Itzhaki (Department of Pharmacology), with Dr Gustavo Gutierrez (AstraZeneca Discovery Sciences), Dr Sharan Bagal (AstraZeneca Oncology Chemistry) and Dr David McGarry (AstraZeneca Oncology Bioscience).
Who can apply
- Applicants who hold, or expect to obtain soon, a first or high 2:1 bachelor's degree from a UK university in a relevant subject, or an equivalent overseas qualification.
- Good knowledge of and/or experience in biochemistry and cell biology.
- An interest in targeted protein degradation and the ability to work independently.
- Overseas students can apply if they meet the UK residency requirements for Home fees, or if they can cover the difference to international fees through scholarships or other funding schemes. You cannot top up the fees from your own money.
How to apply
- Apply through the University of Cambridge postgraduate application portal and choose the PhD in Pharmacology as your course.
- Give the studentship title as your proposed project title.
- Instead of a research proposal, upload one side of A4 covering your motivation, relevant skills, what you hope to achieve and your long-term career plans.
- Quote reference PL51373 in your application and in any correspondence.
The closing date is 8 December 2026. For informal questions about the project, contact Dr Catherine Lindon (acl34@cam.ac.uk). For questions about the application process, contact the Postgraduate Admissions Team.
Requirements
-
Open to all nationalities
-
Undergraduate or Master's
-
Minimum degree: Bachelor's
Funded PhD in Ubiquitin-Independent Targeted Protein Degradation for Oncology
8 Dec 2026 · 16 days left